Marilyn Pike

Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial

Circulation · 2002 · 532 citations

Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind,…

Annals of the Rheumatic Diseases · 2014 · 266 citations